COLL vs LMT · P/E 17, rev $181.9M vs P/E 20, rev $75.05B
Collegium Pharmaceutical Inc (COLL) versus Lockheed Martin Corporation (LMT) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Lockheed Martin Corporation (LMT) is a aerospace & defense company listed on US. It is led by Jim Taiclet.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported LMT revenue for 2025-12-31 was $75.05B. Net income was $5.02B. Revenue was up 5.6% from 2024-12-31 to 2025-12-31. LMT currently screens at market cap $108.37B and trailing P/E 19.9.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. LMT currently screens at market cap $108.37B and trailing P/E 19.9.
Not investment advice. Open the COLL and LMT stock pages for the full models.
Not investment advice.